Therapeutic role of interleukin-1 receptor antagonist in pancreatic diseases: mendelian randomization study.

MLA

Shuai Yuan, et al. “Therapeutic Role of Interleukin-1 Receptor Antagonist in Pancreatic Diseases: Mendelian Randomization Study.” Frontiers in Immunology, Sept. 2023, pp. 1–7. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1240754.

APA

Shuai Yuan, Yuyang Miao, Xixian Ruan, Jie Chen, Xue Li, & Larsson, S. C. (2023). Therapeutic role of interleukin-1 receptor antagonist in pancreatic diseases: mendelian randomization study. Frontiers in Immunology, 1–7. https://doi.org/10.3389/fimmu.2023.1240754

Chicago

Shuai Yuan, Yuyang Miao, Xixian Ruan, Jie Chen, Xue Li, and Susanna C. Larsson. 2023. “Therapeutic Role of Interleukin-1 Receptor Antagonist in Pancreatic Diseases: Mendelian Randomization Study.” Frontiers in Immunology, September, 1–7. doi:10.3389/fimmu.2023.1240754.